Leech M, Leijenaar RTH, Hompland T, Gaffney J, Lyng H, Marignol L(2023) Exploring Hypoxia in Prostate Cancer With T2-weighted Magnetic Resonance Imaging Radiomics and Pimonidazole Scoring Anticancer Res, 43(1), 351-357 DOI 10.21873/anticanres.16170, PubMed 36585179
Lyng H, Skipar K, Hompland T(2022) Targeted Therapy on the Screen: Do We Hit the Target? Clin Cancer Res, 28(24), 5233-5234 DOI 10.1158/1078-0432.CCR-22-2707, PubMed 36240006
Chakravarthy A, Reddin I, Henderson S, Dong C, Kirkwood N, Jeyakumar M, Rodriguez DR, Martinez NG, McDermott J, Su X, Egawa N, Fjeldbo CS, Skingen VE, Lyng H, Halle MK, Krakstad C, Soleiman A, Sprung S, Lechner M, Ellis PJI, Wass M, Michaelis M, Fiegl H, Salvesen H, Thomas GJet al.(2022) Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance Nat Commun, 13(1), 5818 DOI 10.1038/s41467-022-33544-x, PubMed 36207323
Heidi Lyng, Department of Radiation Biology, Institute for Cancer Research Norwegian Radium Hospital, Oslo University Hospital Phone +47 22 78 1478, e-mail: heidi.lyng@rr-research.no
